Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.


Division of Cardiovascular Medicine, Stanford University School of Medicine, Falk Cardiovascular Research Center, Stanford, Calif. Electronic address: [Email]


Phlebolymphedema (chronic venous insufficiency-related lymphedema) is a common and costly condition. Nevertheless, there is a dearth of evidence comparing phlebolymphedema therapeutic interventions. This study sought to examine the medical resource utilization and phlebolymphedema-related cost associated with Flexitouch (FLX; Tactile Medical, Minneapolis, Minn) advanced pneumatic compression devices (APCDs) relative to conservative therapy (CONS) alone, simple pneumatic compression devices (SPCDs), and other APCDs in a representative U.S. population of phlebolymphedema patients.


Cellulitis,Flexitouch,Medical resource utilization,Phlebolymphedema,Pneumatic compression device,Venous ulcer,

OUR Recent Articles